Mannitol Powders for Assessment of Asthma in Children

用于评估儿童哮喘的甘露醇粉末

• 批准号: LP0775441
• 负责人: Prof Hak-Kim Chan
• 金额: $ 9.96万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2007
• 资助国家: 澳大利亚
• 起止时间: 2007-07-24 至 2009-07-23
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0775441
• 关键词: Mannitol; Powders; Assessment; Asthma; Children

A successful conclusion of this project will enable Australia to become a world leader in childhood asthma assessment. The availability of an objective diagnostic test for early detection of asthma would assist formulating early treatment strategies at this crucial stage in the progression of the disease, improving the quality of life of asthma sufferers in their early years. The Australian pharmaceutical sector will benefit through the ability to develop proprietary formulations targeted towards taking advantages of the scientific knowledge on pharmaceutical powders and aerosols. The mannitol testing is environmental friendly as powder aerosol delivery does not require any harmful organic solvents to operate.

该项目的成功完成将使澳大利亚成为儿童哮喘评估的世界领导者。如果能有一个客观的诊断测试来及早发现哮喘，将有助于在疾病发展的这个关键阶段制定早期治疗策略，改善哮喘患者早年的生活质量。 澳大利亚制药部门将受益于开发专有配方的能力，这些配方旨在利用有关药粉和气雾剂的科学知识。甘露醇测试是环境友好的，因为粉末气雾剂递送不需要任何有害的有机溶剂来操作。